A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Laboratory Classroom Study with KP415 in Children with Attention-Deficit/Hyperactivity Disorder
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
KemPharm, Inc
Start Date
May 19, 2017
End Date
August 31, 2019
Administered By
Duke Clinical Research Institute
Awarded By
KemPharm, Inc
Start Date
May 19, 2017
End Date
August 31, 2019